A Multicenter Assessment Of Survival In Patients With Metastatic Renal Cell Carcinoma (Mrcc) Who Received Immune Checkpoint Inhibitor Therapy (Ici) With Or Without Cytoreductive Nephrectomy (Cn)

JOURNAL OF UROLOGY(2021)

引用 1|浏览11
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要